Search results for "PIDE"

showing 10 items of 6055 documents

Musculoskeletal Pain in Gymnasts: A Retrospective Analysis on a Cohort of Professional Athletes

2021

Gymnastics athletes are exposed to a high risk of injury, but also of developing musculoskeletal pain. These data are still little investigated in the available scientific literature. An online survey was distributed to 79 professional athletes who practiced artistic and rhythmic gymnastics. The survey collected demographic and anthropometric data, information about the sport practice, the training sessions, the prevalence of musculoskeletal pain gymnastics-related, and lifestyle habits. Musculoskeletal pain had a high prevalence, involving 65 of 79 athletes (82.3%). A significant correlation was found between musculoskeletal pain and the duration of sports practice, both for general pain (…

musculoskeletal diseasesMusculoskeletal painmedicine.medical_specialtyGymnasticsinjury preventionHealth Toxicology and MutagenesisWrist painoveruseSittingArticlesitting position03 medical and health sciences0302 clinical medicineMusculoskeletal PainInjury preventionmedicineHumanswrist painRight ThighRetrospective StudiesbiologyAthletesbusiness.industryIncidence (epidemiology)RPublic Health Environmental and Occupational Health030229 sport sciencesbiology.organism_classificationAthletesAthletic InjuriesCohortPhysical therapyMedicinemedicine.symptombusinessoverload traininghuman activities030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

MRI findings and physical performance as predictors of flight-induced musculoskeletal pain incidence among fighter pilots

2017

Summary Study aim: The aim of this study was to evaluate the possible association of pre-career magnetic resonance imaging (MRI) find­ings and physical performance level with possible musculoskeletal disorders during jet flight training. Material and methods: The study group consisted of 73 fighter pilots who had undergone pre-career cervical and lumbar spine MRI. Physical performance of a subgroup of the pilots (n = 67) was measured initially at the same time and followed up to the fast jet training phase (ranging from 3.8 to 7.0 years). Musculoskeletal pain history during pilot training was taken from the medical charts. MRI findings and physical performance were associated with perceived…

musculoskeletal diseasesMusculoskeletal painmedicine.medical_specialtyLiikuntatiede - Sport and fitness sciencesPhysiologyeducationKirurgia anestesiologia tehohoito radiologia - Surgery anesthesiology intensive care radiologyPhysical Therapy Sports Therapy and Rehabilitationdisk degenerationcervical spine03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationCervical spineQP1-981MedicineOrthopedics and Sports Medicinemribusiness.industrylumbar spinePublic healthIncidence (epidemiology)030229 sport sciencesCervical spinemilitary pilotfitnessLumbar spinePhysical performanceSports medicinePhysical therapyLumbar spinebusinessRC1200-1245030217 neurology & neurosurgeryMri findingsMRI
researchProduct

Trastuzumab-emtansine induced pleural and pericardial effusions

2021

Introduction Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate which combine trastuzumab (T), a monoclonal antibody targeting the human epidermal growth factor receptor-2 (HER2), and a cytotoxic molecule derived from maytansine (DM1). Case report We report the first case of T-DM1-associated pleural and pericardial effusions three weeks after the second course of T-DM1 in a patient with breast cancer. Drug-induced pleural and pericardial effusions was implicated in the absence of other etiologies. The Naranjo Scale indicated a probable drug-induced adverse reaction. Management & outcome: The patient fully recovered after thoracentesis and discontinuation of T-DM1. The patient h…

musculoskeletal diseasesReceptor ErbB-2medicine.drug_classBreast NeoplasmsAdo-Trastuzumab EmtansineAntibodies Monoclonal HumanizedMonoclonal antibodyPericardial effusionPericardial Effusion03 medical and health scienceschemistry.chemical_compound0302 clinical medicineTrastuzumabmedicineHumansMaytansinePharmacology (medical)business.industryHuman epidermal growth factorTrastuzumabmedicine.diseaseOncologychemistryTrastuzumab emtansine030220 oncology & carcinogenesisCancer researchFemalebusiness030215 immunologymedicine.drugConjugateJournal of Oncology Pharmacy Practice
researchProduct

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adju…

2014

5 Office-based Professional Association Gynecologic Oncologists e.V. in Germany (BNGO e.V.), Berlin; 6 Background: This prospective study evaluated the relationship between arthralgia and compliance during the first year of adjuvant anastrozole therapy in postmenopausal women with hormone receptor-positive early breast cancer. Patients and methods: COMPliance and Arthralgia in Clinical Therapy (COMPACT) was an open-label, multicenter, noninterventional study conducted in Germany. Patients had started adjuvant anastrozole 3-6 months before the study start. The primary end points were arthralgia, compliance, and the relationship between compliance and arthralgia, assessed at specific time poi…

musculoskeletal diseasesmedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.medical_treatmentSpecific timeAnastrozoleBreast NeoplasmsAnastrozoleMedication AdherenceBreast cancerInternal medicineNitrilesmedicineHumansProspective Studiesskin and connective tissue diseasesProspective cohort studyAgedbusiness.industryDrug SubstitutionIncidence (epidemiology)IncidenceHematologyMiddle AgedTriazolesmedicine.diseaseArthralgiaSurgeryCompliance (physiology)Clinical therapyTreatment OutcomeOncologyChemotherapy AdjuvantFemalebusinessAdjuvantmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

The Epidemiology of Hip and Knee Primary and Revision Arthroplasties during the COVID-19 Pandemic

2021

Background: The purpose of this study was to provide a comprehensive assessment of the impact of the COVID-19 pandemic on the epidemiology of primary and revision arthroplasties of the hip and knee joint. Methods: This study compared the data on knee and hip arthroplasty procedures from 2 hospitals (primary and revision) conducted in two periods: the period of the COVID-19 pandemic in Poland (from 4 March 2020 to 15 October 2020) and the corresponding period prior to the pandemic (from 4 March 2019 to 15 October 2019). We compared the epidemiological data, demographic data, and hospital stay duration data from these two periods. Results: Our analysis demonstrated that the total number of hi…

musculoskeletal diseasesmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Leadership and Managementmedicine.medical_treatmentKnee replacementHealth InformaticsSARS-COV-2Knee JointArticle03 medical and health sciences0302 clinical medicineHealth Information ManagementEpidemiologyPandemicmedicineDuration data030222 orthopedicsknee revisionknee arthroplastiesbusiness.industryhip arthroplastiesHealth Policypandemiclock-downR030229 sport sciencesArthroplastySurgeryOrthopedic surgeryMedicineepidemiologyhip revisionbusinessCovid-19knee arthroplasties; hip arthroplasties; knee revision; hip revision; Covid-19; epidemiology; lock-down; pandemic; SARS-COV-2Healthcare
researchProduct

Is time to joint replacement a valid outcome measure in clinical trials of drugs for osteoarthritis?

2003

The rate of radiographic joint space narrowing is commonly used today as a structural outcome measure in clinical trials evaluating potential disease-modifying drugs in patients with hip osteoarthritis, but this results in a continuous variable. Among the methods proposed to circumvent this problem, it has been suggested that the incidence of total hip arthoplasty (THA) provides a hard outcome measure. It is a dichotomized variable, easy to measure and sensitive to change, with acceptable intrinsic validity. However, because this measure is limited by the variability of factors underlying the decision to perform surgery and the length of waiting lists, it has been suggested that time to ful…

musculoskeletal diseasesmedicine.medical_specialtyTime FactorsJoint replacementEndpoint Determinationmedicine.medical_treatmentArthroplasty Replacement HipInternational CooperationMeasure (physics)OsteoarthritisContinuous variableRheumatologyReference ValuesArthropathyOsteoarthritismedicineHumansClinical Trials as Topicbusiness.industryIncidence (epidemiology)Outcome measuresmedicine.diseaseClinical trialTreatment OutcomePhysical therapybusinessRheumatic diseases clinics of North America
researchProduct

Levetiracetam‐induced pediatric toxic epidermal necrolysis successfully treated with etanercept

2020

Successful management of toxic epidermal necrolysis (TEN) with tumor necrosis factor-α inhibitors has been described in adults, but few cases have been reported in children. To date, only four pediatric cases of TEN treated with infliximab and one with etanercept have been published. We present the case of an 8-year-old boy diagnosed with TEN induced by levetiracetam, successfully treated with etanercept, systemic corticosteroids, and intravenous immunoglobulin.

musculoskeletal diseasesmedicine.medical_specialtybiologybusiness.industryDermatologymedicine.diseaseDermatologyToxic epidermal necrolysisInfliximabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPediatrics Perinatology and Child Healthbiology.proteinmedicineTumor necrosis factor alphaLevetiracetamAntibodyskin and connective tissue diseasesbusinessmedicine.drugPediatric Dermatology
researchProduct

AB1394 Compliance and arthralgias in clinical therapy (compact): Assessment of the incidence of arthralgia, therapy costs and compliance within the f…

2013

Background Aromatase inhibitors (AI) are well established as adjuvant endocrine treatment for postmenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC). Drug-induced myalgia or arthralgia is among the most frequently reported adverse drug reactions to AIs. Objectives Little is known about the pathomechanism by which AIs cause muscle and joint injury. The literature on skeletal muscle complaints with AIs is confusing, in part because of a lack of clear definitions. Myalgia/arthralgia is defined as muscle/joint pain and is likely to affect patients’ quality of life and compliance with AI medication . We designed a prospective trial to collect real world data on the e…

musculoskeletal diseasesmyalgiamedicine.medical_specialtybusiness.industryIncidence (epidemiology)ImmunologyAnastrozolemedicine.diseaseGeneral Biochemistry Genetics and Molecular Biologybody regionsTherapy complianceBreast cancerRheumatologyQuality of lifeInternal medicineJoint painConcomitantmedicinePhysical therapyImmunology and Allergymedicine.symptombusinessmedicine.drugAnnals of the Rheumatic Diseases
researchProduct

Helena-muunnelmat

2021

muunnelmatantiikin mytologiaHelena (tragedia Euripides)Euripidesnäytelmäkirjallisuuskäännöksettragediat
researchProduct

COVID‐19 in older adults: What are the differences with younger patients?

2020

Aim The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic me…

myalgiaAdultMalemedicine.medical_specialtyAdolescentFevercoronavirusComorbiditySerology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicine030502 gerontologyCOVID‐19Risk FactorsInternal medicinemedicineHumansHospital Mortalityclinical characteristicsolder adultsOxygen saturation (medicine)AgedRetrospective StudiesAged 80 and overCreatininebusiness.industrySARS-CoV-2Medical recordAge FactorsCOVID-19Retrospective cohort studyOdds ratioOriginal ArticlesMiddle AgedmortalityConfidence intervalHospitalizationchemistryCoughSpainORIGINAL ARTICLE: Epidemiology Clinical Practice and HealthFemalemedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgeryGeriatrics & Gerontology International
researchProduct